找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: HDL Metabolism and Diseases; Lemin Zheng Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Na

[復(fù)制鏈接]
樓主: abandon
11#
發(fā)表于 2025-3-23 11:38:30 | 只看該作者
The Future of Risk Management, Volume IIC, while it is also claimed that CETP weakens atherosclerosis formation by promoting RCT. Currently, the CETP-related drugs are still immature. Research on CETP inhibitors is targeted at improving efficacy and minimizing adverse reactions. As for CETP agonists, research has proved that they also can be used to resist atherosclerosis.
12#
發(fā)表于 2025-3-23 17:52:01 | 只看該作者
13#
發(fā)表于 2025-3-23 20:28:48 | 只看該作者
14#
發(fā)表于 2025-3-24 00:27:11 | 只看該作者
https://doi.org/10.1007/978-1-349-20369-7lipoprotein (HDL) particles, and ABCG1 facilitates subsequent continued cholesterol efflux to HDL for further maturation. In this chapter, we summarize the roles of ABCA1 and ABCG1 in maintaining cellular cholesterol homoeostasis and discuss the underlying mechanisms by which they mediate cholesterol export.
15#
發(fā)表于 2025-3-24 04:31:42 | 只看該作者
16#
發(fā)表于 2025-3-24 06:55:42 | 只看該作者
17#
發(fā)表于 2025-3-24 13:03:33 | 只看該作者
HDL and Endothelial Function,ial functions, lots of cardiovascular diseases such as atherosclerosis could not be fully prevented and treated. Thus, a further understanding of the relationship between HDL and endothelial cell is needed, which would create a potential therapeutic approach to cardiovascular diseases.
18#
發(fā)表于 2025-3-24 16:43:06 | 只看該作者
19#
發(fā)表于 2025-3-24 21:23:18 | 只看該作者
ABCA1, ABCG1, and Cholesterol Homeostasis,lipoprotein (HDL) particles, and ABCG1 facilitates subsequent continued cholesterol efflux to HDL for further maturation. In this chapter, we summarize the roles of ABCA1 and ABCG1 in maintaining cellular cholesterol homoeostasis and discuss the underlying mechanisms by which they mediate cholesterol export.
20#
發(fā)表于 2025-3-25 03:12:19 | 只看該作者
HDL and Therapy, apolipoprotein mimetic peptides like apoA-I and and apoE mimetics have undergone clinical assessment, and we have also reviewed the advances of clinical trials and gave an outlook for the therapy of rHDL and mimetic peptides.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 08:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
东丽区| 高青县| 四平市| 柳林县| 浦北县| 拜泉县| 信宜市| 平泉县| 青田县| 阳春市| 绥江县| 西城区| 赤峰市| 当雄县| 南溪县| 嘉峪关市| 清苑县| 霍城县| 太保市| 中方县| 郸城县| 松溪县| 濉溪县| 太康县| 南皮县| 册亨县| 浙江省| 民乐县| 武胜县| 尼勒克县| 宁陵县| 宣汉县| 宜川县| 龙游县| 明光市| 惠来县| 洱源县| 平定县| 额济纳旗| 上高县| 宁阳县|